Search
Guardant Health Inc
GHAdd to Watchlist
131.780USD
+2.670+2.07%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
17.22BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Guardant Health Inc is 8.75, ranking 15 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 100.00, with a high of 130.00 and a low of 48.21.
Analyst Rating
Based on
26
analysts
Buy
Current Rating
143.627
Target Price
+11.24%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Guardant Health Inc
GH
26
Medtronic PLC
MDT
33
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Guardant Health Inc's expected revenue for the next quarter?
Guardant Health Inc's expected revenue is 314.64M.
What is Guardant Health Inc's price target?
Analysts forecast that Guardant Health Inc's price target is USD 100.00, with the highest forecast at USD 130.00 and the lowest forecast at USD 48.21.
How have Guardant Health IncGH's recent earnings per share performed?
The market expectation was USD -0.85, while Guardant Health IncGH's earnings per share (EPS) for the previous quarter was USD -1.00. EPS for the next quarter is expected at USD -0.39.
What is the analyst rating for Guardant Health Inc?
Based on the ratings of Guardant Health Inc's stock from 26 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
